Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Johnson’s research is focused on predictive toxicology and network pharmacology utilizing computational methodology to analyze chemical-biological interactions, model structure activity relationships, and analyze perturbations in systems biology pathways. These technologies are being applied to solve problems in environmental toxicity, side effects associated with human therapeutics, and interactions between Traditional Chinese Medicines and Western therapeutics.Through his affiliation with Emiliem, Inc. his research involves novel compounds that are multi-kinase inhibitors. With Elara Bioscience his work involves the creation of enterprise applications for information used in chemical safety applications and green chemistry initiatives, particularly in the chemical design process. Elara Bioscience has established the Elarabio Molecular Toxicology Internships at UC Berkeley, where student interns are creating and applying software tools, website-based applications, and social media into on-line and secure transfer information tools and systems.
His research interests Includes Biotechnology, toxicology, Microbiology, Chemistry, analytical chemistry Predictive toxicology and network pharmacology utilizing
Dale E. Johnson
Editorial: J Drug Metab Toxicol 2013